Etchegaray, A.; Haffner, D.; Cruz, S.M.; Ogunleye, O.; Xia, J.; Schlegel, A.; Olutoye, O.O.; Chaudhari, B.P.
Early Neonatal Fosdenopterin Treatment for Molybdenum Cofactor Deficiency Type A: New Insights into Its Natural History and Potential Role for Fetal Therapy. J. Clin. Med. 2025, 14, 3561.
https://doi.org/10.3390/jcm14103561
AMA Style
Etchegaray A, Haffner D, Cruz SM, Ogunleye O, Xia J, Schlegel A, Olutoye OO, Chaudhari BP.
Early Neonatal Fosdenopterin Treatment for Molybdenum Cofactor Deficiency Type A: New Insights into Its Natural History and Potential Role for Fetal Therapy. Journal of Clinical Medicine. 2025; 14(10):3561.
https://doi.org/10.3390/jcm14103561
Chicago/Turabian Style
Etchegaray, Adolfo, Darrah Haffner, Stephanie M. Cruz, Oluseyi Ogunleye, Jason Xia, Amy Schlegel, Oluyinka O. Olutoye, and Bimal P. Chaudhari.
2025. "Early Neonatal Fosdenopterin Treatment for Molybdenum Cofactor Deficiency Type A: New Insights into Its Natural History and Potential Role for Fetal Therapy" Journal of Clinical Medicine 14, no. 10: 3561.
https://doi.org/10.3390/jcm14103561
APA Style
Etchegaray, A., Haffner, D., Cruz, S. M., Ogunleye, O., Xia, J., Schlegel, A., Olutoye, O. O., & Chaudhari, B. P.
(2025). Early Neonatal Fosdenopterin Treatment for Molybdenum Cofactor Deficiency Type A: New Insights into Its Natural History and Potential Role for Fetal Therapy. Journal of Clinical Medicine, 14(10), 3561.
https://doi.org/10.3390/jcm14103561
